"Driver-passenger" bacteria and their metabolites in the pathogenesis of colorectal cancer

Gut Microbes. 2021 Jan-Dec;13(1):1941710. doi: 10.1080/19490976.2021.1941710.

Abstract

Colorectal cancer (CRC) is a significant public health problem accounting for about 10% of all new cancer cases globally. Though genetic and epigenetic factors influence CRC, the gut microbiota acts as a significant component of the disease's etiology. Further research is still needed to clarify the specific roles and identify more bacteria related to CRC development. This review aims to provide an overview of the "driver-passenger" model of CRC. The colonization and active invasion of the "driver(s)" bacteria cause damages allowing other commensals, known as "passengers," or their by-products, i.e., metabolites, to pass through the epithelium . This review will not only focus on the species of bacteria implicated in this model but also on their biological functions implicated in the occurrence of CRC, such as forming biofilms, mucus, penetration and production of enterotoxins and genotoxins.

Keywords: Colorectal cancer; biofilm; driver-passenger; metabolites; microbiome; mucus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bacteria / metabolism*
  • Biomarkers, Tumor
  • Carcinogenesis / chemically induced*
  • Carcinogenesis / pathology*
  • Colorectal Neoplasms / etiology*
  • Colorectal Neoplasms / microbiology*
  • Colorectal Neoplasms / physiopathology*
  • Disease Progression
  • Gastrointestinal Microbiome*
  • Humans

Substances

  • Biomarkers, Tumor

Grants and funding

This work was supported by UW start-up fund (RWD)